Entry |
|
Symbol |
MIRLET7
|
Name |
|
Pathway |
map05207 | Chemical carcinogenesis - receptor activation |
|
Brite |
KEGG Orthology (KO) [BR:ko00001]
09150 Organismal Systems
09158 Development and regeneration
04361 Axon regeneration
K16980 MIRLET7; microRNA let-7
09160 Human Diseases
09161 Cancer: overview
05206 MicroRNAs in cancer
K16980 MIRLET7; microRNA let-7
05207 Chemical carcinogenesis - receptor activation
K16980 MIRLET7; microRNA let-7
09180 Brite Hierarchies
09183 Protein families: signaling and cellular processes
04147 Exosome
K16980 MIRLET7; microRNA let-7
09184 RNA family
03100 Non-coding RNAs
K16980 MIRLET7; microRNA let-7
Exosome [BR:ko04147]
Exosomal RNA
Exosomal RNA of breast milk
K16980 MIRLET7; microRNA let-7
Exosomal RNA of saliva
K16980 MIRLET7; microRNA let-7
Exosomal RNA of ovarian cancer cells
K16980 MIRLET7; microRNA let-7
Exosomal RNA of renal carcinoma cells
K16980 MIRLET7; microRNA let-7
Exosomal RNA of other cancer cells
K16980 MIRLET7; microRNA let-7
Non-coding RNAs [BR:ko03100]
Other eukaryotic RNA
Micro RNA
K16980 MIRLET7; microRNA let-7
|
Genes |
» show all
|
Reference |
|
Authors |
Peter ME |
Title |
Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. |
Journal |
|
Sequence |
|
Reference |
|
Authors |
Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T |
Title |
Identification of novel genes coding for small expressed RNAs. |
Journal |
|
Sequence |
|
Reference |
|
Authors |
Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ |
Title |
RAS is regulated by the let-7 microRNA family. |
Journal |
|
Reference |
|
Authors |
Law YY, Lee WF, Hsu CJ, Lin YY, Tsai CH, Huang CC, Wu MH, Tang CH, Liu JF |
Title |
miR-let-7c-5p and miR-149-5p inhibit proinflammatory cytokine production in osteoarthritis and rheumatoid arthritis synovial fibroblasts. |
Journal |
|
Sequence |
|
Reference |
|
Authors |
Siragam V, Rutnam ZJ, Yang W, Fang L, Luo L, Yang X, Li M, Deng Z, Qian J, Peng C, Yang BB |
Title |
MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11. |
Journal |
|
Sequence |
|
LinkDB |
|